Literature DB >> 23927693

NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery.

Kasper W Jørgensen1, Michael Rasmussen, Søren Buus, Morten Nielsen.   

Abstract

Major histocompatibility complex class I (MHC-I) molecules play an essential role in the cellular immune response, presenting peptides to cytotoxic T lymphocytes (CTLs) allowing the immune system to scrutinize ongoing intracellular production of proteins. In the early 1990s, immunogenicity and stability of the peptide-MHC-I (pMHC-I) complex were shown to be correlated. At that time, measuring stability was cumbersome and time consuming and only small data sets were analysed. Here, we investigate this fairly unexplored area on a large scale compared with earlier studies. A recent small-scale study demonstrated that pMHC-I complex stability was a better correlate of CTL immunogenicity than peptide-MHC-I affinity. We here extended this study and analysed a total of 5509 distinct peptide stability measurements covering 10 different HLA class I molecules. Artificial neural networks were used to construct stability predictors capable of predicting the half-life of the pMHC-I complex. These predictors were shown to predict T-cell epitopes and MHC ligands from SYFPEITHI and IEDB to form significantly more stable MHC-I complexes compared with affinity-matched non-epitopes. Combining the stability predictions with a state-of-the-art affinity predictions NetMHCcons significantly improved the performance for identification of T-cell epitopes and ligands. For the HLA alleles included in the study, we could identify distinct sub-motifs that differentiate between stable and unstable peptide binders and demonstrate that anchor positions in the N-terminal of the binding motif (primarily P2 and P3) play a critical role for the formation of stable pMHC-I complexes. A webserver implementing the method is available at www.cbs.dtu.dk/services/NetMHCstab.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  MHC-peptide stability; cytotoxic T lymphocyte epitopes; immunoinformatics; peptide immunogenicity

Mesh:

Substances:

Year:  2014        PMID: 23927693      PMCID: PMC3893846          DOI: 10.1111/imm.12160

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

Review 1.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.

Authors:  A Sette; J Sidney
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

Review 2.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

3.  Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.

Authors:  Morten Nielsen; Claus Lundegaard; Peder Worning; Sanne Lise Lauemøller; Kasper Lamberth; Søren Buus; Søren Brunak; Ole Lund
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

4.  Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.

Authors:  K C Parker; M A Bednarek; L K Hull; U Utz; B Cunningham; H J Zweerink; W E Biddison; J E Coligan
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

5.  Definition of supertypes for HLA molecules using clustering of specificity matrices.

Authors:  Ole Lund; Morten Nielsen; Can Kesmir; Anders Gorm Petersen; Claus Lundegaard; Peder Worning; Christina Sylvester-Hvid; Kasper Lamberth; Gustav Røder; Sune Justesen; Søren Buus; Søren Brunak
Journal:  Immunogenetics       Date:  2004-02-13       Impact factor: 2.846

6.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

7.  Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach.

Authors:  Massimo Andreatta; Ole Lund; Morten Nielsen
Journal:  Bioinformatics       Date:  2012-10-24       Impact factor: 6.937

8.  MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL.

Authors:  D H Busch; E G Pamer
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

9.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

Authors:  K C Parker; M A Bednarek; J E Coligan
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

10.  Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.

Authors:  S H van der Burg; M J Visseren; R M Brandt; W M Kast; C J Melief
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  48 in total

1.  A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.

Authors:  Lasse Eggers Pedersen; Michael Rasmussen; Mikkel Harndahl; Morten Nielsen; Søren Buus; Gregers Jungersen
Journal:  Immunogenetics       Date:  2015-11-14       Impact factor: 2.846

2.  Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.

Authors:  Michael Rasmussen; Emilio Fenoy; Mikkel Harndahl; Anne Bregnballe Kristensen; Ida Kallehauge Nielsen; Morten Nielsen; Søren Buus
Journal:  J Immunol       Date:  2016-07-08       Impact factor: 5.422

3.  NetTepi: an integrated method for the prediction of T cell epitopes.

Authors:  Thomas Trolle; Morten Nielsen
Journal:  Immunogenetics       Date:  2014-05-27       Impact factor: 2.846

Review 4.  Tools to define the melanoma-associated immunopeptidome.

Authors:  Eva Bräunlein; Angela M Krackhardt
Journal:  Immunology       Date:  2017-08-28       Impact factor: 7.397

Review 5.  Antitumour dendritic cell vaccination in a priming and boosting approach.

Authors:  Alexandre Harari; Michele Graciotti; Michal Bassani-Sternberg; Lana E Kandalaft
Journal:  Nat Rev Drug Discov       Date:  2020-08-06       Impact factor: 84.694

6.  NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.

Authors:  Vanessa Jurtz; Sinu Paul; Massimo Andreatta; Paolo Marcatili; Bjoern Peters; Morten Nielsen
Journal:  J Immunol       Date:  2017-10-04       Impact factor: 5.422

7.  In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes.

Authors:  Julien Schmidt; Philippe Guillaume; Danijel Dojcinovic; Julia Karbach; George Coukos; Immanuel Luescher
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

8.  High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity Predictions.

Authors:  Dylan T Blaha; Scott D Anderson; Daniel M Yoakum; Marlies V Hager; Yuanyuan Zha; Thomas F Gajewski; David M Kranz
Journal:  Cancer Immunol Res       Date:  2018-11-13       Impact factor: 11.151

9.  The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.

Authors:  Thomas Trolle; Curtis P McMurtrey; John Sidney; Wilfried Bardet; Sean C Osborn; Thomas Kaever; Alessandro Sette; William H Hildebrand; Morten Nielsen; Bjoern Peters
Journal:  J Immunol       Date:  2016-01-18       Impact factor: 5.422

Review 10.  Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different.

Authors:  Chung-Han Lee; Roman Yelensky; Karin Jooss; Timothy A Chan
Journal:  Trends Immunol       Date:  2018-05-08       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.